These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6448639)

  • 21. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medium effects on the kinetics of human plasmin.
    Yang H
    Thromb Res; 1992 Feb; 65(3):377-88. PubMed ID: 1385909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
    Bock PE
    J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of the urokinase-catalyzed activation of human plasminogen.
    Violand BN; Castellino FJ
    J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
    Wu TP; Yee V; Tulinsky A; Chrusciel RA; Nakanishi H; Shen R; Priebe C; Kahn M
    Protein Eng; 1993 Jul; 6(5):471-8. PubMed ID: 8415574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New class of sensitive and selective fluorogenic substrates for serine proteinases. Amino acid and dipeptide derivatives of rhodamine.
    Leytus SP; Patterson WL; Mangel WF
    Biochem J; 1983 Nov; 215(2):253-60. PubMed ID: 6228222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
    Ellis V; Scully MF; Kakkar VV
    J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotin derivatives of D-Phe-Pro-Arg-CH2Cl for active-site-specific labeling of thrombin and other serine proteinases.
    Anderson PJ; Bock PE
    Anal Biochem; 2001 Sep; 296(2):254-61. PubMed ID: 11554721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N alpha-tosyl-L-lysyl-chloromethylketone on the activity of cytotoxic T lymphocytes.
    Chang TW; Eisen HN
    J Immunol; 1980 Mar; 124(3):1028-33. PubMed ID: 6987305
    [No Abstract]   [Full Text] [Related]  

  • 31. Irreversible inhibition of trypsin by TLCK. A continuous method for kinetic study of irreversible enzymatic inhibitors in the presence of substrate.
    Tudela J; Garcia-Canovas F; Garcia-Carmona F; Iborra JL; Lozano JA
    Int J Biochem; 1986; 18(3):285-8. PubMed ID: 3956844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of potential activators of proteinase-activated receptor-2.
    Fox MT; Harriott P; Walker B; Stone SR
    FEBS Lett; 1997 Nov; 417(3):267-9. PubMed ID: 9409730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin.
    Backes BJ; Harris JL; Leonetti F; Craik CS; Ellman JA
    Nat Biotechnol; 2000 Feb; 18(2):187-93. PubMed ID: 10657126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
    Hughes FM; Evans-Storms RB; Cidlowski JA
    Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protamine, a substrate for thrombolytic agents and enzymes of similar specificity.
    Ong EB; Johnson AJ
    Anal Biochem; 1976 Oct; 75(2):568-82. PubMed ID: 136215
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of smooth muscle responses by serine proteases and related enzymes.
    Fareed J; Kindel G; Kumar A
    Semin Thromb Hemost; 1986 Oct; 12(4):265-76. PubMed ID: 3097826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
    Kettner C; Shaw E
    Biochemistry; 1978 Oct; 17(22):4778-84. PubMed ID: 728386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone.
    Kupfer A; Gani V; Jiménez JS; Shaltiel S
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3073-7. PubMed ID: 226953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
    Bock PE
    Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.